← Leaderboards
Chetan Seshadri
University Of Washington
$9,942,409
Attributed
$10,060,123
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,296,165 · 7
By mechanism
R01$8,114,293 · 2
P30$5,547,477 · 4
K08$634,395 · 1
Top collaborators
- Rhea N Coler5 shared
- David R Sherman5 shared
Most similar at University Of Washington
Same institution · by research overlap
- Kevin B Urdahl$13,507,707
- Thomas R Hawn$19,135,026
- Roy C Page$840,208
- Caryl Feldacker$3,160,613
- Eben Kenah$3,818,579
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingTuberculosisMycobacterium TuberculosisCollaborationsEpidemicImmune SystemT Cell ResponseVaccinationMycobacterium BovisAntigensPhenotypePeptidesCommunitiesCd1 AntigensTuberculosis VaccinesMycobacterialCell WallLipidsT-LymphocyteVaccinesNovel VaccinesChildAdultUnited States National Institutes Of Health
Grant awards (25)
Seattle Tuberculosis Research Advancement Center$1,037,189
P30 · FY2025 · AI · contact PI
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis$989,186
R01 · FY2025 · AI · contact PI
Administrative Core$345,581
P30 · FY2025 · AI · contact PI
Core-004$176,571
P30 · FY2025 · AI · contact PI
Seattle Tuberculosis Research Advancement Center$1,037,189
P30 · FY2024 · AI · contact PI
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis$802,099
R01 · FY2024 · AI · contact PI
Administrative Core$302,003
P30 · FY2024 · AI · contact PI
Seattle Tuberculosis Research Advancement Center$1,043,145
P30 · FY2023 · AI · contact PI
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis$809,949
R01 · FY2023 · AI · contact PI
Administrative Core$263,575
P30 · FY2023 · AI · contact PI
Seattle Tuberculosis Research Advancement Center$1,118,519
P30 · FY2022 · AI · contact PI
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis$805,629
R01 · FY2022 · AI · contact PI
Administrative Core$223,705
P30 · FY2022 · AI · contact PI
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis$801,468
R01 · FY2021 · AI · contact PI
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis$834,105
R01 · FY2020 · AI · contact PI
Qualification of Assays to Measure Human T-cell Responses Against Mycobacterial Lipid Antigens$652,173
R01 · FY2020 · AI · contact PI
Qualification of Assays to Measure Human T-cell Responses Against Mycobacterial Lipid Antigens$572,000
R01 · FY2019 · AI · contact PI
Qualification of Assays to Measure Human T-cell Responses Against Mycobacterial Lipid Antigens$467,872
R01 · FY2018 · AI · contact PI
Qualification of Assays to Measure Human T-cell Responses Against Mycobacterial Lipid Antigens$361,476
R01 · FY2017 · AI · contact PI
Qualification of Assays to Measure Human T-cell Responses Against Mycobacterial Lipid Antigens$1,018,336
R01 · FY2016 · AI · contact PI
The Role of CD1a in Protecting Against Human Tuberculosis$126,874
K08 · FY2014 · AI · contact PI
The Role of CD1a in Protecting Against Human Tuberculosis$126,863
K08 · FY2013 · AI · contact PI
The Role of CD1a in Protecting Against Human Tuberculosis$126,892
K08 · FY2012 · AI · contact PI
The Role of CD1a in Protecting Against Human Tuberculosis$126,874
K08 · FY2011 · AI · contact PI
The Role of CD1a in Protecting Against Human Tuberculosis$126,892
K08 · FY2010 · AI · contact PI